Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experimental studies on the hemolytic-uremic syndrome.

R P Bolande, B S Kaplan

    Nephron
    |January 1, 1985
    PubMed
    Summary

    Hemolytic-uremic syndrome (HUS) involves red blood cell damage and platelet injury. Toxins from gut bacteria may trigger these HUS-related changes, impacting hemolysis and thrombolysis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Haemolytic uraemic syndrome associated with Pseudomonas aeruginosa sepsis.

    Journal of medical microbiology·2013
    Same author

    Dent disease presenting as partial Fanconi syndrome and hypercalciuria.

    Kidney international·2008
    Same author

    An update on the hemolytic uremic syndrome.

    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia·2008
    Same author

    Glomerular epithelial cell arachidonate metabolism in Shiga toxin hemolytic uremic syndrome.

    Kidney international·2001
    Same author

    HUS or not HUS?

    Pediatric nephrology (Berlin, Germany)·2001
    Same author

    Improve survival with plasma exchange thrombotic thrombopenic purpura-hemolytic uremic syndrome.

    The American journal of medicine·2001

    Area of Science:

    • Hematology
    • Pathology
    • Microbiology

    Background:

    • Hemolytic-uremic syndrome (HUS) presents with acute kidney injury, thrombocytopenia, and microangiopathic hemolytic anemia.
    • Ultrastructural examination of blood cells in HUS patients reveals significant erythrocyte and platelet alterations.

    Purpose of the Study:

    • To investigate the ultrastructural changes in blood cells during HUS.
    • To explore the potential role of bacterial toxins in HUS pathogenesis.
    • To establish an in vitro and in vivo model to study HUS-related cellular damage.

    Main Methods:

    • Ultrastructural analysis of erythrocytes and platelets from HUS patients.
    • In vitro treatment of red blood cells with purified clostridial phospholipase C.
    • In vivo studies involving phospholipase C infusion in rats.

    Main Results:

    • Erythrocytes showed membrane disruption, vacuolar degeneration, and Heinz body formation.
    • Platelet injury and interactions between histiocytes and damaged red cells were observed.
    • Phospholipase C treatment induced red cell and platelet changes comparable to HUS; rats developed hemolysis, thrombocytopenia, and hemoglobinuria but lacked characteristic glomerular kidney damage.

    Conclusions:

    • Bacterial phospholipase C can induce HUS-like blood cell changes.
    • Gut-derived toxins may initiate HUS by causing intestinal mucosal injury, leading to systemic effects.
    • Further research is needed to fully elucidate the role of toxins in HUS-induced renal injury.

    Related Experiment Videos